Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211.SZ) SHZ
9.85
-0.13(-1.30%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.4B |
| Enterprise Value | 3.95B |
| P/E Ratio | 121.32 |
| PEG Ratio | -2.53 |
| Price/Sales Ratio | 6.16 |
| Price/Book Ratio | 1.8 |
| Enterprise/Revenue | 5.24 |
| Enterprise/EBITDA | 35.67 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | -0 |
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 453.31M |
| Revenue/Share | 1.1 |
| Gross Profit | 100.2M |
| EBITDA | 84.81M |
| Net Income | 34.91M |
| Diluted EPS | 0.1 |
Balance Sheet
| Total Cash | 1.54B |
| Total Cash/Share | 3.69 |
| Total Debt | 2.35M |
| Total Debt/Equity | 0 |
| Current Ratio | 17.18 |
| Book Value Per Share | 5.47 |
Price History
| 52-Week Change | -21.44 |
| 52-Week High | 16.95 |
| 52-Week Low | 9.76 |
| Moving Average 50 Days | 11.48 |
| Moving Average 200 Days | 12.61 |
Statistics
| Average Volume | 3.77M |
| Shares Outstanding | 288M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 2.13 |
| Last Split Factor | 29:20 |
| Last Split Date | August 27, 2025 |
